Search results for: 'ez captm cy5 firefly luciferase mrna 5 mo utp'
-
R1010 EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)19 CitationSummary: Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation -
R1018 EZ Cap™ Firefly Luciferase mRNA19 CitationSummary: Firefly Luciferase mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability. -
R1013 EZ Cap™ Firefly Luciferase mRNA (5-moUTP)24 CitationSummary: Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1105 Enhanced EZ Cap™ Firefly Luciferase mRNASummary: Sequence-optimized firefly luciferase mRNA with Cap 1 structure, significantly enhances the protein expression efficiency -
R1004 EZ Cap™ Firefly Luciferase mRNA (m1Ψ)Summary: Firefly Luciferase mRNA with Cap 1 structure, modified by m1Ψ,providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1017 EZ Cap™ mCherry mRNA (5mCTP, ψUTP)4 CitationSummary: mCherry mRNA with Cap 1 structure, modified by 5mCTP/ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1106 Enhanced EZ Cap™ Firefly Luciferase mRNA (5-moUTP)Summary: Sequence-optimized firefly luciferase mRNA with Cap 1 structure, modified by 5-moUTP, significantly enhances the protein expression efficiency -
R1107 Enhanced EZ Cap™ Firefly Luciferase mRNA (m1Ψ)Summary: Sequence-optimized firefly luciferase mRNA with Cap 1 structure, modified by m1Ψ, significantly enhances the protein expression efficiency -
R1012 Firefly Luciferase mRNA (ARCA, 5-moUTP)4 CitationSummary: Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control. -
R1011 EZ Cap™ Cy5 EGFP mRNA (5-moUTP)15 CitationSummary: EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

